tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PTGX Stock Latest News

Protagonist Therapeutics price target raised to $67 from $51 at BTIG
The FlyProtagonist Therapeutics price target raised to $67 from $51 at BTIG
4d ago
LLY
PTGX
Protagonist Therapeutics selects PN-881 as development candidate
PremiumThe Fly
Protagonist Therapeutics selects PN-881 as development candidate
4d ago
PTGX
Protagonist and JNJ say icotrokinra study for PsO meets endpoint
PremiumThe Fly
Protagonist and JNJ say icotrokinra study for PsO meets endpoint
7d ago
JNJ
PTGX
Protagonist Therapeutics Reports Strong Financial Turnaround
PremiumCompany Announcements
Protagonist Therapeutics Reports Strong Financial Turnaround
18d ago
PTGX
Wedbush starts Protagonist Therapeutics with an Outperform, $58 target
PremiumThe Fly
Wedbush starts Protagonist Therapeutics with an Outperform, $58 target
21d ago
PTGX
Protagonist Therapeutics initiated with an Outperform at Wedbush
PremiumThe FlyProtagonist Therapeutics initiated with an Outperform at Wedbush
21d ago
PTGX
PTGX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PTGX Upcoming Earnings Report: What to Expect?
22d ago
PTGX
Protagonist Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
Protagonist Therapeutics participates in a conference call with JPMorgan
2M ago
PTGX
Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Walmart upgraded, Starbucks downgraded: Wall Street’s top analyst calls
2M ago
CRM
DAY
Protagonist Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
Protagonist Therapeutics initiated with a Buy at TD Cowen
2M ago
PTGX
Protagonist Therapeutics Board and Audit Committee Changes
PremiumCompany Announcements
Protagonist Therapeutics Board and Audit Committee Changes
2M ago
8K
PTGX
Protagonist Therapeutics price target raised to $50 from $40 at H.C. Wainwright
PremiumThe Fly
Protagonist Therapeutics price target raised to $50 from $40 at H.C. Wainwright
2M ago
PTGX
Protagonist Therapeutics initiated with a Buy at Truist
PremiumThe FlyProtagonist Therapeutics initiated with a Buy at Truist
3M ago
PTGX
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
Premium
The Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
4M ago
JNJ
TAK
Protagonist Therapeutics price target raised to $40 from $38 at H.C. Wainwright
Premium
The Fly
Protagonist Therapeutics price target raised to $40 from $38 at H.C. Wainwright
4M ago
PTGX
Protagonist Therapeutics sees cash runway through end of 2027
PremiumThe Fly
Protagonist Therapeutics sees cash runway through end of 2027
4M ago
PTGX
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
PremiumThe Fly
Protagonist Therapeutics reports Q2 EPS (50c), consensus (60c)
4M ago
PTGX
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
PremiumThe Fly
Protagonist Therapeutics announces publication of clinical data on JNJ-2113
4M ago
PTGX
Protagonist Therapeutics appoints Newman Yeilding as chief scientific advisor
PremiumThe Fly
Protagonist Therapeutics appoints Newman Yeilding as chief scientific advisor
4M ago
PTGX
Protagonist Therapeutics price target raised to $51 from $41 at BTIG
PremiumThe FlyProtagonist Therapeutics price target raised to $51 from $41 at BTIG
4M ago
PTGX
Protagonist Therapeutics to replace Encore Wire in S&P 600 at open on 7/3
Premium
The Fly
Protagonist Therapeutics to replace Encore Wire in S&P 600 at open on 7/3
5M ago
PTGX
WIRE
3 Best Stocks to Buy Now, 6/17/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 6/17/2024, According to Top Analysts 
5M ago
SLM
PTGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >